UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 478

Sortiert nach

Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease

Journal of neuroinflammation, 2019-06, Vol.16 (1), p.129-129, Article 129

2019

Link zum Volltext

Verfügbarkeit prüfen

Gut microenvironmental changes as a potential trigger in Parkinson’s disease through the gut–brain axis

Journal of biomedical science, 2022-07, Vol.29 (1), p.54-54, Article 54

2022

Link zum Volltext

Verfügbarkeit prüfen

A clinical and genetic study of early‐onset and familial parkinsonism in taiwan: An integrated approach combining gene dosage analysis and next‐generation sequencing

Movement disorders, 2019-04, Vol.34 (4), p.506-515

2019

Link zum Volltext

Verfügbarkeit prüfen

Minimal Detectable Change of the Timed “Up & Go” Test and the Dynamic Gait Index in People With Parkinson Disease

Physical therapy, 2011-01, Vol.91 (1), p.114-121

2011

Link zum Volltext

Verfügbarkeit prüfen

Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study

PloS one, 2014-06, Vol.9 (6), p.e98961-e98961

2014

Link zum Volltext

Verfügbarkeit prüfen

Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease

Journal Of Movement Disorders, 2019, 12(2), , pp.67-83

2019

Link zum Volltext

Verfügbarkeit prüfen

Novel Phenotype of 6p25 Deletion Syndrome Presenting Juvenile Parkinsonism and Brain Calcification

Movement disorders, 2020-08, Vol.35 (8), p.1457-1462

2020

Link zum Volltext

Verfügbarkeit prüfen

Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice Through Activating TNF‐α Pathway

Movement disorders, 2022-04, Vol.37 (4), p.745-757

2022

Link zum Volltext

Verfügbarkeit prüfen

The Gut Metabolite Trimethylamine N‐oxide Is Associated With Parkinson's Disease Severity and Progression

Movement disorders, 2020-11, Vol.35 (11), p.2115-2116

2020

Link zum Volltext

Verfügbarkeit prüfen

A Double‐Blind, Randomized, Controlled Trial of Lovastatin in Early‐Stage Parkinson's Disease

Movement disorders, 2021-05, Vol.36 (5), p.1229-1237

2021

Link zum Volltext

Verfügbarkeit prüfen

Amyloid related cerebral microbleed and plasma Aβ40 are associated with cognitive decline in Parkinson's disease

Scientific reports, 2021-03, Vol.11 (1), p.7115-7115, Article 7115

2021

Link zum Volltext

Verfügbarkeit prüfen

Amantadine treatment and delayed onset of levodopa‐induced dyskinesia in patients with early Parkinson's disease

European journal of neurology, 2022-04, Vol.29 (4), p.1044-1055

2022

Link zum Volltext

Verfügbarkeit prüfen

Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review

BMC neurology, 2020-03, Vol.20 (1), p.101-101, Article 101

2020

Link zum Volltext

Verfügbarkeit prüfen

PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista Junctions

Molecular cell, 2018-03, Vol.69 (5), p.744-756.e6

2018

Link zum Volltext

Verfügbarkeit prüfen

Genetic study of young‐onset dementia using targeted gene panel sequencing in Taiwan

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2021-03, Vol.186 (2), p.67-76

2021

Link zum Volltext

Verfügbarkeit prüfen

Blood neurofilament light chain as a surrogate marker for dystonia

European journal of neurology, 2023-10, Vol.30 (10), p.3098-3104

2023

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic Heterogeneity in Patients with Mutations in the Mitochondrial Complex I Assembly Gene NDUFAF5

Movement disorders, 2023-12, Vol.38 (12), p.2217-2229

2023

Link zum Volltext

Verfügbarkeit prüfen

Detection and Classification of Stroke Gaits by Deep Neural Networks Employing Inertial Measurement Units

Sensors (Basel, Switzerland), 2021-03, Vol.21 (5), p.1864

2021

Link zum Volltext

Verfügbarkeit prüfen

The HSP40 family chaperone isoform DNAJB6b prevents neuronal cells from tau aggregation

BMC biology, 2023-12, Vol.21 (1), p.293-293, Article 293

2023

Link zum Volltext

Verfügbarkeit prüfen

Glial Nrf2 signaling mediates the neuroprotection exerted by Gastrodia elata Blume in Lrrk2-G2019S Parkinson's disease

eLife, 2021-11, Vol.10

2021

Link zum Volltext

Verfügbarkeit prüfen

COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition

European journal of neurology, 2022-10, Vol.29 (10), p.2956-2966

2022

Link zum Volltext

Verfügbarkeit prüfen

Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism

Movement disorders, 2019-12, Vol.34 (12), p.1882-1890

2019

Link zum Volltext

Verfügbarkeit prüfen

Pain in early-stage Parkinson's disease: Implications from clinical features to pathophysiology mechanisms

Journal of the Formosan Medical Association, 2017-08, Vol.116 (8), p.571-581

2017

Link zum Volltext

Verfügbarkeit prüfen

In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation

Stem cell research & therapy, 2021-09, Vol.12 (1), p.508-508, Article 508

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk of Parkinson's disease following severe constipation: A nationwide population-based cohort study

Parkinsonism & related disorders, 2014-12, Vol.20 (12), p.1371-1375

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 478

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(407)
Mit Volltextzugriff
(452)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(324)
Life Sciences & Biomedicine
(212)
Humans
(147)
Technology
(103)
Neurosciences & Neurology
(99)
Male
(86)
Parkinson's Disease
(86)
Female
(80)
Physical Sciences
(78)
Engineering
(72)
Middle Aged
(72)
Clinical Neurology
(68)
Engineering, Electrical & Electronic
(59)
Aged
(52)
Adult
(49)
Physics
(48)
Movement Disorders
(42)
Neurosciences
(42)
Physics, Applied
(42)
Neurology
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease

Gut microenvironmental changes as a potential trigger in Parkinson’s disease through the gut–brain axis

A clinical and genetic study of early‐onset and familial parkinsonism in taiwan: An integrated approach combining gene dosage analysis and next‐generation sequencing

Minimal Detectable Change of the Timed “Up & Go” Test and the Dynamic Gait Index in People With Parkinson Disease

Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study

Altered Gut Microbiome and Intestinal Pathology in Parkinson’s Disease

Novel Phenotype of 6p25 Deletion Syndrome Presenting Juvenile Parkinsonism and Brain Calcification

Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice Through Activating TNF‐α Pathway

The Gut Metabolite Trimethylamine N‐oxide Is Associated With Parkinson's Disease Severity and Progression

A Double‐Blind, Randomized, Controlled Trial of Lovastatin in Early‐Stage Parkinson's Disease

Amyloid related cerebral microbleed and plasma Aβ40 are associated with cognitive decline in Parkinson's disease

Amantadine treatment and delayed onset of levodopa‐induced dyskinesia in patients with early Parkinson's disease

Genotype-phenotype correlations of adult-onset PLA2G6-associated Neurodegeneration: case series and literature review

PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista Junctions

Genetic study of young‐onset dementia using targeted gene panel sequencing in Taiwan

Blood neurofilament light chain as a surrogate marker for dystonia

Phenotypic Heterogeneity in Patients with Mutations in the Mitochondrial Complex I Assembly Gene NDUFAF5

Detection and Classification of Stroke Gaits by Deep Neural Networks Employing Inertial Measurement Units

The HSP40 family chaperone isoform DNAJB6b prevents neuronal cells from tau aggregation

Glial Nrf2 signaling mediates the neuroprotection exerted by Gastrodia elata Blume in Lrrk2-G2019S Parkinson's disease

COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition

Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism

Pain in early-stage Parkinson's disease: Implications from clinical features to pathophysiology mechanisms

In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation

Risk of Parkinson's disease following severe constipation: A nationwide population-based cohort study

Suchergebnisse filtern